Immunohistochemistry (IHC) staining results of Her2, ER, PR and Ki67 expression in breast cancer tissue were shown in Figure 2A. Initially, we examined the prognostic difference between cancer subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.